Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eli Lilly | Milan | Healthcare | Pharmaceuticals | €595.01B | 62.9x | 0.77 | €662.80 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Johnson Johnson | Milan | Healthcare | Pharmaceuticals | €318.69B | 17.4x | -0.41 | €132.54 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbvie | Milan | Healthcare | Pharmaceuticals | €283.86B | 80.7x | -2.55 | €159.80 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amgen | Milan | Healthcare | Pharmaceuticals | €136.15B | 27x | 0.45 | €253.65 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pfizer | Milan | Healthcare | Pharmaceuticals | €122.51B | 18.3x | 0.01 | €21.55 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gilead Sciences | Milan | Healthcare | Pharmaceuticals | €118.02B | 23.4x | 0.02 | €94.58 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sanofi | Milan | Healthcare | Pharmaceuticals | €101.47B | 16.7x | 0.41 | €83.12 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vertex Pharmaceuticals | Milan | Healthcare | Pharmaceuticals | €100.21B | -112.4x | 0.92 | €388.60 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bristol Myers Squibb | Milan | Healthcare | Pharmaceuticals | €81.07B | 17.6x | 0.09 | €39.77 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zoetis | Milan | Healthcare | Pharmaceuticals | €60.17B | 28.5x | 3.77 | €133.84 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Milan | Healthcare | Pharmaceuticals | €48.37B | 17.2x | 4.89 | €111.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Merck | Milan | Healthcare | Pharmaceuticals | €48.37B | 11.8x | 0.02 | €68.80 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bayer | Milan | Healthcare | Pharmaceuticals | €25.73B | -7.9x | 1.69 | €26.09 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biogen | Milan | Healthcare | Pharmaceuticals | €16.53B | 13.1x | 0.47 | €112.25 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Incyte | Milan | Healthcare | Pharmaceuticals | €11.25B | 624.5x | -6.41 | €58.74 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recordati | Milan | Healthcare | Pharmaceuticals | €11.15B | 26.6x | 3.5 | €54.05 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.3% Upside | Upgrade to Pro+ | |
Biomarin Pharmaceutical | Milan | Healthcare | Pharmaceuticals | €9.36B | 20.8x | 0.13 | €49.10 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Viatris | Milan | Healthcare | Pharmaceuticals | €9.29B | -2.8x | 0 | €7.86 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orion Oyj | Milan | Healthcare | Pharmaceuticals | €8.88B | 25.5x | 0.43 | €62.45 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Swedish Orphan Biovitrum AB | Milan | Healthcare | Pharmaceuticals | €8.78B | 24.9x | 0.31 | €25.22 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Grifols | Milan | Healthcare | Pharmaceuticals | €6.44B | 37x | €10.54 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Organon | Milan | Healthcare | Pharmaceuticals | €2.20B | 3.5x | -0.12 | €8.46 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmanutra | Milan | Healthcare | Pharmaceuticals | €447.51M | 28.5x | 0.9 | €46.60 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorio Farmaceutico Erfo | Milan | Healthcare | Pharmaceuticals | €11.11M | 25.2x | -0.79 | €1.30 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |